Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Quick Stats
Mar 31, 202652.4
AI Score
HOLD0.19
Volume Ratio
May 06, 2026
Next Earnings
12
+ve Days (30d)
18
-ve Days (30d)
NAGE Stock Summary
Last updated Mar 31, 2026
NAGE is currently trading at $4.42, positioned below its 200-day moving average of $7.87, suggesting bearish momentum. The stock has a 52-week range of $4.16 to $14.69.
Technical Analysis: The 50-day moving average stands at $5.17, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.801, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.197, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NAGE at 52.4/100 with a HOLD recommendation.
NAGE (Niagen Bioscience, Inc. Common Stock) Indicators
Last updated Mar 31, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 35.801 |
| CMF (20) | -0.197 |
| ROC (10) | -8.176 |
| ADX (14) | 21.779 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.242 |
| AROONOSC (14) | -92.857 |
| WILLAMS %R (14) | -73.965 |
| MFI (14) | 24.855 |
NAGE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NAGE Price vs Max Options Open Interest
NAGE Max Change In Options Open Interest
NAGE Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAGE Daily Out of Money Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAGE Daily In the Money Options - Sort by Max open Interest (near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAGE Most Active Options by Volume(near term)
31st March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Niagen Bioscience, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NAGE Moving Averages Analysis
NAGE (Niagen Bioscience, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Mar 31, 2026
| Days | MA |
|---|---|
| 10 | 4.51 |
| 20 | 4.73 |
| 30 | 4.83 |
| 50 | 5.17 |
| 100 | 5.9 |
| 200 | 7.87 |
NAGE Fundamental Analysis
| P/E (Forward) | 19.4175 |
| P/E (Trailing) | 21 |
| Market Cap ($) | 336.3 million |
| Earnings/Share ($) | 0.2 |
| Net Proft Margin (%) | 0.1343 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.265 |
| EPS Estimate Next Year ($) | 0.345 |
| WallStreet Target Price ($) | 13.6 |
| Most Recent Quarter |